Rethinking Endothelial Dysfunction as a Crucial Target in Fighting Heart Failure.
Mayo Clin Proc Innov Qual Outcomes
; 3(1): 1-13, 2019 Mar.
Article
em En
| MEDLINE
| ID: mdl-30899903
Ach, acetylcholine; CAD, coronary artery disease; CVD, cardiovascular disease; ECFC, endothelial colony-forming cell; EDHF, endothelium-derived hyperpolarizing factor; EPC, endothelial progenitor cell; EPC-CFU, EPCcolony-forming unit; FMD, flow-mediated vasodilation; H2O2, hydrogen peroxide; HF, heart failure; HFpEF, HF with preserved ejection fraction; HFrEF, HF with reduced ejection fraction; IVUS, intravascular ultrasound; LVEF, left ventricular ejection fraction; NO, nitric oxide; NOS, NO synthase; PAT, peripheral arterial tonometry; QCA, quantitative coronary angiography; ROS, reactive oxygen species; cGMP, cyclic guanosine monophosphate; eNOS, endothelial nitric oxide synthase
Texto completo:
1
Base de dados:
MEDLINE
Tipo de estudo:
Risk_factors_studies
Idioma:
En
Ano de publicação:
2019
Tipo de documento:
Article